(April 14, 2023, 2:10 PM EDT) -- WASHINGTON, D.C. — The United States and Danco Laboratories LLC on April 14 applied to the U.S. Supreme Court for a stay of federal district court and appeals court rulings affecting the approval of the abortion drug mifepristone, with Danco saying the high court might have to grant certiorari before an appellate court judgment and “set this case for expedited briefing and argument before the summer recess.”...